Evan Melrose is the founding managing director of Spindletop Capital in Austin. Prior to Spindletop, he was founding managing director of PTV Sciences, an Austin venture capital firm, and a director with Burrill & Company, a San Francisco-based private equity/venture capital firm. While at Burrill he managed investments on behalf of limited partners including IBM, Aventis, Proctor & Gamble, ADM, and Bayer. Dr. Melrose has public board and operating experience including partnerships and IPOs. Current and prior board membership include Bioventus, QSpex, Avanzar Medical, IntersectENT, Asuragen, BioSET, BioForm Medical (Nasdaq: BFRM), Biomimetic Therapeutics (Nasdaq: BMTI), Inhibitex (Nasdaq: INHX), and Insite Vision. He has held faculty appointments at the UCSF, UPenn, and currently at Baylor College of Medicine. His primary care practice included obstetrics, pediatrics, and emergency medicine.